Zapletal, O.; Žatecký, J.; Gabrielová, L.; Selingerová, I.; Holánek, M.; Burkoň, P.; Coufal, O.
Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection. Cancers 2025, 17, 178.
https://doi.org/10.3390/cancers17020178
AMA Style
Zapletal O, Žatecký J, Gabrielová L, Selingerová I, Holánek M, Burkoň P, Coufal O.
Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection. Cancers. 2025; 17(2):178.
https://doi.org/10.3390/cancers17020178
Chicago/Turabian Style
Zapletal, Ondřej, Jan Žatecký, Lucie Gabrielová, Iveta Selingerová, Miloš Holánek, Petr Burkoň, and Oldřich Coufal.
2025. "Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection" Cancers 17, no. 2: 178.
https://doi.org/10.3390/cancers17020178
APA Style
Zapletal, O., Žatecký, J., Gabrielová, L., Selingerová, I., Holánek, M., Burkoň, P., & Coufal, O.
(2025). Axillary Overtreatment in Patients with Breast Cancer After Neoadjuvant Chemotherapy in the Current Era of Targeted Axillary Dissection. Cancers, 17(2), 178.
https://doi.org/10.3390/cancers17020178
